HIPSCORE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

HIPSCORE Trademark

Serial Number: 98686425 • Registration: 8091273

HIPSCORE is a trademark filed by IUF Leibniz-Institut für umweltmedizinische Forschung GmbH on August 7, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

IUF Leibniz-Institut für umweltmedizinische Forschung GmbH

Auf'm Hennekamp 50
Düsseldorf 40225 , DE

Entity Type: 16

Trademark Details

Filing Date

August 7, 2024

Registration Date

January 6, 2026

Published for Opposition

November 18, 2025

Goods & Services

Tissues for surgical use being surgical implants comprised of living tissues based on human induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for mesodermal cells or a part of a gene specific for mesodermal cells for medical and pharmaceutical use, in particular, for the analysis of human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for mesodermal cells or a part of a gene specific for mesodermal cells for medical and pharmaceutical use using human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for endodermal cells or a part of a gene specific for endodermal cells for medical and pharmaceutical use, in particular, for the analysis of human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for endodermal cells or a part of a gene specific for endodermal cells for medical and pharmaceutical use using human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for ectodermal cells or a part of a gene specific for ectodermal cells for medical and pharmaceutical use, in particular, for the analysis of human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for ectodermal cells or a part of a gene specific for ectodermal cells for medical and pharmaceutical use using human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for pluripotent cells or a part of a gene specific for pluripotent cells for medical and pharmaceutical use, in particular, for the analysis of human-induced pluripotent stem cells; diagnostic agents and materials, namely, amplification primers for amplifying a gene specific for pluripotent cells or a part of a gene specific for pluripotent cells for medical and pharmaceutical use using human-induced pluripotent stem cells

Scientific and technological services;, namely, scientific research, analysis, testing, and evaluation in the field of human-induced pluripotent stem cells; Scientific and technological services, namely, testing in the field of human-induced pluripotent stem cells; authentication in the field of human-induced pluripotent stem cells; quality control for others in the field of human-induced pluripotent stem cells

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 6, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 6, 2026 R.PR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 24, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 24, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 24, 2025 COAR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 12, 2025 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 16, 2025 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 26, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 26, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 26, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 26, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 26, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 12, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 12, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 12, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 13, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 13, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 13, 2025 CNRT
ASSIGNED TO EXAMINER
Feb 12, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 22, 2025 NWOS
NEW APPLICATION ENTERED
Aug 7, 2024 NWAP